Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-118512
Filing Date
2023-04-26
Accepted
2023-04-26 16:08:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d483467ddefa14a.htm DEFA14A 11266
2 GRAPHIC g483467dsp002.jpg GRAPHIC 169451
3 GRAPHIC g483467dsp003.jpg GRAPHIC 38054
  Complete submission text file 0001193125-23-118512.txt   288120
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39269 | Film No.: 23849784
SIC: 2834 Pharmaceutical Preparations